Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0299 Transporter Info | ||||
Gene Name | SLC35D2 | ||||
Transporter Name | UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Prostate cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC35D2 in prostate cancer | [ 1 ] | |||
Location |
5'UTR (cg02305261) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.80E+00 | Statistic Test | p-value: 2.98E-02; Z-score: 3.07E+00 | ||
Methylation in Case |
5.53E-01 (Median) | Methylation in Control | 3.07E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC35D2 in prostate cancer | [ 1 ] | |||
Location |
Body (cg05157486) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.49E+00 | Statistic Test | p-value: 1.00E-02; Z-score: -2.28E+00 | ||
Methylation in Case |
2.15E-01 (Median) | Methylation in Control | 3.20E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC35D2 in prostate cancer | [ 1 ] | |||
Location |
Body (cg16190510) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.52E+00 | Statistic Test | p-value: 2.58E-02; Z-score: -3.02E+00 | ||
Methylation in Case |
4.20E-01 (Median) | Methylation in Control | 6.36E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC35D2 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg13771161) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.84E+00 | Statistic Test | p-value: 6.60E-11; Z-score: -8.64E+00 | ||
Methylation in Case |
3.84E-01 (Median) | Methylation in Control | 7.08E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC35D2 in bladder cancer | [ 2 ] | |||
Location |
Body (cg21216944) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 6.06E-05; Z-score: -3.01E+00 | ||
Methylation in Case |
8.26E-01 (Median) | Methylation in Control | 8.79E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC35D2 in bladder cancer | [ 2 ] | |||
Location |
Body (cg14331316) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.61E+00 | Statistic Test | p-value: 1.74E-04; Z-score: 4.42E+00 | ||
Methylation in Case |
7.82E-01 (Median) | Methylation in Control | 4.87E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC35D2 in bladder cancer | [ 2 ] | |||
Location |
Body (cg13519061) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.07E+00 | Statistic Test | p-value: 1.03E-03; Z-score: -3.80E+00 | ||
Methylation in Case |
8.44E-01 (Median) | Methylation in Control | 9.02E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC35D2 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
TSS1500 (cg13771161) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.16E+00 | Statistic Test | p-value: 2.94E-06; Z-score: -2.35E+00 | ||
Methylation in Case |
6.96E-01 (Median) | Methylation in Control | 8.04E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC35D2 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
Body (cg00430036) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.75E+00 | Statistic Test | p-value: 6.74E-04; Z-score: 1.11E+00 | ||
Methylation in Case |
2.21E-01 (Median) | Methylation in Control | 1.26E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC35D2 in HIV infection | [ 4 ] | |||
Location |
TSS1500 (cg13771161) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 1.93E-04; Z-score: -1.29E+00 | ||
Methylation in Case |
7.75E-01 (Median) | Methylation in Control | 8.24E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC35D2 in HIV infection | [ 4 ] | |||
Location |
Body (cg00430036) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.44E+00 | Statistic Test | p-value: 7.43E-09; Z-score: 2.58E+00 | ||
Methylation in Case |
5.49E-01 (Median) | Methylation in Control | 3.82E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC35D2 in HIV infection | [ 4 ] | |||
Location |
Body (cg15582789) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.74E+00 | Statistic Test | p-value: 1.94E-08; Z-score: 2.93E+00 | ||
Methylation in Case |
3.66E-01 (Median) | Methylation in Control | 2.11E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC35D2 in HIV infection | [ 4 ] | |||
Location |
Body (cg21216944) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 5.37E-03; Z-score: -5.49E-01 | ||
Methylation in Case |
8.87E-01 (Median) | Methylation in Control | 8.97E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC35D2 in systemic lupus erythematosus | [ 5 ] | |||
Location |
TSS1500 (cg13771161) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 1.02E-02; Z-score: -2.64E-01 | ||
Methylation in Case |
7.25E-01 (Median) | Methylation in Control | 7.68E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC35D2 in systemic lupus erythematosus | [ 5 ] | |||
Location |
Body (cg14331316) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.57E-02; Z-score: -2.36E-01 | ||
Methylation in Case |
8.84E-01 (Median) | Methylation in Control | 8.90E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC35D2 in pancretic ductal adenocarcinoma | [ 6 ] | |||
Location |
TSS200 (cg06898199) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 3.34E-02; Z-score: -3.37E-01 | ||
Methylation in Case |
5.90E-02 (Median) | Methylation in Control | 6.43E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC35D2 in pancretic ductal adenocarcinoma | [ 6 ] | |||
Location |
Body (cg14122373) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.20E+00 | Statistic Test | p-value: 3.27E-06; Z-score: 1.40E+00 | ||
Methylation in Case |
5.61E-01 (Median) | Methylation in Control | 4.66E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC35D2 in pancretic ductal adenocarcinoma | [ 6 ] | |||
Location |
Body (cg14634247) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.12E+00 | Statistic Test | p-value: 2.19E-03; Z-score: -6.30E-01 | ||
Methylation in Case |
1.18E-01 (Median) | Methylation in Control | 1.32E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC35D2 in pancretic ductal adenocarcinoma | [ 6 ] | |||
Location |
Body (cg08455719) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.01E+00 | Statistic Test | p-value: 2.56E-02; Z-score: 4.27E-01 | ||
Methylation in Case |
7.96E-01 (Median) | Methylation in Control | 7.85E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC35D2 in pancretic ductal adenocarcinoma | [ 6 ] | |||
Location |
Body (cg21938718) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.01E+00 | Statistic Test | p-value: 2.83E-02; Z-score: 1.10E-01 | ||
Methylation in Case |
8.10E-01 (Median) | Methylation in Control | 8.03E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Atypical teratoid rhabdoid tumor |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC35D2 in atypical teratoid rhabdoid tumor | [ 7 ] | |||
Location |
Body (cg00430036) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.16E+00 | Statistic Test | p-value: 2.50E-05; Z-score: -1.15E+00 | ||
Methylation in Case |
7.32E-01 (Median) | Methylation in Control | 8.47E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC35D2 in atypical teratoid rhabdoid tumor | [ 7 ] | |||
Location |
Body (cg13519061) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.12E+00 | Statistic Test | p-value: 3.69E-02; Z-score: 4.93E-01 | ||
Methylation in Case |
6.63E-01 (Median) | Methylation in Control | 5.93E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC35D2 in atypical teratoid rhabdoid tumor | [ 7 ] | |||
Location |
Body (cg14331316) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.09E+00 | Statistic Test | p-value: 4.57E-02; Z-score: 8.29E-01 | ||
Methylation in Case |
8.06E-01 (Median) | Methylation in Control | 7.39E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC35D2 in breast cancer | [ 8 ] | |||
Location |
Body (cg21216944) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 3.86E-14; Z-score: -2.09E+00 | ||
Methylation in Case |
8.29E-01 (Median) | Methylation in Control | 8.73E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC35D2 in breast cancer | [ 8 ] | |||
Location |
Body (cg00430036) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.82E+00 | Statistic Test | p-value: 2.70E-10; Z-score: 2.38E+00 | ||
Methylation in Case |
2.68E-01 (Median) | Methylation in Control | 1.47E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC35D2 in breast cancer | [ 8 ] | |||
Location |
Body (cg15582789) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.67E+00 | Statistic Test | p-value: 1.03E-09; Z-score: 2.54E+00 | ||
Methylation in Case |
1.70E-01 (Median) | Methylation in Control | 1.02E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC35D2 in breast cancer | [ 8 ] | |||
Location |
Body (cg14331316) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.17E+00 | Statistic Test | p-value: 2.00E-04; Z-score: -1.56E+00 | ||
Methylation in Case |
6.61E-01 (Median) | Methylation in Control | 7.76E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC35D2 in breast cancer | [ 8 ] | |||
Location |
Body (cg13519061) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.06E-02; Z-score: -2.85E-01 | ||
Methylation in Case |
8.76E-01 (Median) | Methylation in Control | 8.83E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC35D2 in colon adenocarcinoma | [ 9 ] | |||
Location |
Body (cg00145985) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.45E+00 | Statistic Test | p-value: 2.90E-06; Z-score: -3.47E+00 | ||
Methylation in Case |
5.22E-01 (Median) | Methylation in Control | 7.58E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC35D2 in colon adenocarcinoma | [ 9 ] | |||
Location |
Body (cg12384004) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.40E+00 | Statistic Test | p-value: 1.40E-04; Z-score: -2.31E+00 | ||
Methylation in Case |
4.31E-01 (Median) | Methylation in Control | 6.02E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC35D2 in colorectal cancer | [ 10 ] | |||
Location |
Body (cg21216944) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 5.89E-05; Z-score: -9.30E-01 | ||
Methylation in Case |
9.22E-01 (Median) | Methylation in Control | 9.36E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC35D2 in colorectal cancer | [ 10 ] | |||
Location |
Body (cg14331316) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 1.81E-02; Z-score: -5.68E-01 | ||
Methylation in Case |
8.93E-01 (Median) | Methylation in Control | 9.23E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC35D2 in hepatocellular carcinoma | [ 11 ] | |||
Location |
Body (cg15582789) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.64E+00 | Statistic Test | p-value: 4.55E-07; Z-score: -1.25E+00 | ||
Methylation in Case |
1.15E-01 (Median) | Methylation in Control | 1.89E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC35D2 in hepatocellular carcinoma | [ 11 ] | |||
Location |
Body (cg00430036) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.54E+00 | Statistic Test | p-value: 3.89E-06; Z-score: -1.10E+00 | ||
Methylation in Case |
1.97E-01 (Median) | Methylation in Control | 3.03E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC35D2 in hepatocellular carcinoma | [ 11 ] | |||
Location |
Body (cg21216944) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 8.07E-06; Z-score: -6.38E-01 | ||
Methylation in Case |
7.95E-01 (Median) | Methylation in Control | 8.29E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC35D2 in lung adenocarcinoma | [ 12 ] | |||
Location |
Body (cg21216944) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 6.99E-06; Z-score: -3.77E+00 | ||
Methylation in Case |
8.61E-01 (Median) | Methylation in Control | 9.05E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC35D2 in lung adenocarcinoma | [ 12 ] | |||
Location |
Body (cg00430036) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.66E+00 | Statistic Test | p-value: 6.06E-05; Z-score: 3.82E+00 | ||
Methylation in Case |
5.13E-01 (Median) | Methylation in Control | 3.10E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC35D2 in lung adenocarcinoma | [ 12 ] | |||
Location |
Body (cg15582789) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.98E+00 | Statistic Test | p-value: 2.53E-04; Z-score: 4.70E+00 | ||
Methylation in Case |
4.12E-01 (Median) | Methylation in Control | 2.08E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC35D2 in panic disorder | [ 13 ] | |||
Location |
Body (cg00430036) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -8.48E-01 | Statistic Test | p-value: 4.72E-03; Z-score: -3.59E-01 | ||
Methylation in Case |
-1.37E+00 (Median) | Methylation in Control | -1.16E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC35D2 in papillary thyroid cancer | [ 14 ] | |||
Location |
Body (cg13519061) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.19E+00 | Statistic Test | p-value: 2.09E-17; Z-score: 2.16E+00 | ||
Methylation in Case |
8.70E-01 (Median) | Methylation in Control | 7.31E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC35D2 in papillary thyroid cancer | [ 14 ] | |||
Location |
Body (cg21216944) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 3.09E-05; Z-score: -7.97E-01 | ||
Methylation in Case |
9.39E-01 (Median) | Methylation in Control | 9.47E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC35D2 in papillary thyroid cancer | [ 14 ] | |||
Location |
Body (cg00430036) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.42E+00 | Statistic Test | p-value: 7.50E-03; Z-score: 8.23E-01 | ||
Methylation in Case |
1.60E-01 (Median) | Methylation in Control | 1.13E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
microRNA |
|||||
Unclear Phenotype |
17 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
miR-193b directly targets SLC35D2 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Microarray | ||
miRNA Stemloop ID |
miR-193b | miRNA Mature ID | miR-193b-3p | ||
miRNA Sequence |
AACUGGCCCUCAAAGUCCCGCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
miR-26b directly targets SLC35D2 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Microarray | ||
miRNA Stemloop ID |
miR-26b | miRNA Mature ID | miR-26b-5p | ||
miRNA Sequence |
UUCAAGUAAUUCAGGAUAGGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human cervical cancer cell line (Hela) | ||||
Epigenetic Phenomenon 3 |
miR-3123 directly targets SLC35D2 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3123 | miRNA Mature ID | miR-3123 | ||
miRNA Sequence |
CAGAGAAUUGUUUAAUC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 4 |
miR-34b directly targets SLC35D2 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-34b | miRNA Mature ID | miR-34b-3p | ||
miRNA Sequence |
CAAUCACUAACUCCACUGCCAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 5 |
miR-3614 directly targets SLC35D2 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3614 | miRNA Mature ID | miR-3614-5p | ||
miRNA Sequence |
CCACUUGGAUCUGAAGGCUGCCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 6 |
miR-3929 directly targets SLC35D2 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3929 | miRNA Mature ID | miR-3929 | ||
miRNA Sequence |
GAGGCUGAUGUGAGUAGACCACU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 7 |
miR-4478 directly targets SLC35D2 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4478 | miRNA Mature ID | miR-4478 | ||
miRNA Sequence |
GAGGCUGAGCUGAGGAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 8 |
miR-451b directly targets SLC35D2 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-451b | miRNA Mature ID | miR-451b | ||
miRNA Sequence |
UAGCAAGAGAACCAUUACCAUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 9 |
miR-485 directly targets SLC35D2 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-485 | miRNA Mature ID | miR-485-5p | ||
miRNA Sequence |
AGAGGCUGGCCGUGAUGAAUUC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 10 |
miR-5690 directly targets SLC35D2 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-5690 | miRNA Mature ID | miR-5690 | ||
miRNA Sequence |
UCAGCUACUACCUCUAUUAGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 11 |
miR-6500 directly targets SLC35D2 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6500 | miRNA Mature ID | miR-6500-3p | ||
miRNA Sequence |
ACACUUGUUGGGAUGACCUGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 12 |
miR-6746 directly targets SLC35D2 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6746 | miRNA Mature ID | miR-6746-5p | ||
miRNA Sequence |
CCGGGAGAAGGAGGUGGCCUGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 13 |
miR-6771 directly targets SLC35D2 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6771 | miRNA Mature ID | miR-6771-5p | ||
miRNA Sequence |
CUCGGGAGGGCAUGGGCCAGGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 14 |
miR-6828 directly targets SLC35D2 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6828 | miRNA Mature ID | miR-6828-5p | ||
miRNA Sequence |
AGGAAGCAAGAGAACCCUGUGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 15 |
miR-6884 directly targets SLC35D2 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6884 | miRNA Mature ID | miR-6884-5p | ||
miRNA Sequence |
AGAGGCUGAGAAGGUGAUGUUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 16 |
miR-7977 directly targets SLC35D2 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-7977 | miRNA Mature ID | miR-7977 | ||
miRNA Sequence |
UUCCCAGCCAACGCACCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 17 |
miR-98 directly targets SLC35D2 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Microarray | ||
miRNA Stemloop ID |
miR-98 | miRNA Mature ID | miR-98-5p | ||
miRNA Sequence |
UGAGGUAGUAAGUUGUAUUGUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human cervical cancer cell line (Hela) | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.